Navigation Links
New protein discovered by Hebrew University researchers

Researchers at the Hebrew University of Jerusalem have succeeded in discovering and isolating a new protein from the poplar tree with special structural and qualitative characteristics that could have consequences for development of future nanocapsules for drug delivery to cancer cells. In addition to being obtained from plant tissue, the protein can now also be produced in large quantities as a recombinant protein in bacteria, making it highly available for medicinal or other applications. Called SP-1, the protein has a nanometric, "bagel-shaped," circular form and is extremely stable. It has been found to be capable of surviving contact with enzymes that break down proteins or exposure to extreme conditions such as boiling, excessive acidity, salinity, organic solvents or detergent solutions.

The research was conducted at the Hebrew University's Faculty of Agricultural, Food and Environmental Quality Sciences in Rehovot by Prof. Arie Altman, head of the faculty's Institute of Plant Sciences and Genetics in Agriculture, and Prof. Oded Shoseyov, with the participation of Dr. Wangxia Wang and Dr. Dan Pelah and the scientists of Fulcrum SP Ltd.: Dr. Amnon Wolf, Dr. Ira Marton and Dr. Yonatan Puny. According to Profs. Altman and Shoseyov, the SP-1 protein serves to assist in creating a properly folded and functioning structure of other proteins within the plant's cells. The SP-1 also has the ability to assemble itself into a structure composed of 12 identical units, making it exceptionally resistant to extreme conditions. These qualities are rarely found among proteins and make the SP-1 a promising candidate for a multiplicity of uses in developing medicinal applications in the rapidly growing field of nanobiotechnology. SP-1 nanocapsules will be capable of delivering cell-destroying drugs specifically to certain types of solid cancer tumors. The protein's tiny structure enables this carrier to penetrate specifically into tumors without harming healthy tissue an d thus enhance the effectiveness of chemotherapy. This selective penetration is based on the fact that the blood vessels which feed tumors are considerably more porous than those reaching healthy cells. Therefore, the units of SP-1 carrying the drug would invade only the tumor-feeding blood vessels and not normal ones. More recently, the three-dimensional structure of the protein was deciphered by x-ray crystallography. The research on this was published in the Journal of Biological Chemistry issue of December 2004, authored by graduate student Orna Dgany, Prof. Altman and Prof. Shoseyov, in cooperation with Dr. Orna Almog of Ben-Gurion University of the Negev and Dr. Sharon Wolf of the Weizmann Institute of Science and other researchers. Prof. Altman and Prof. Shoseyov are the scientific founders of the biotech start-up company Fulcrum SP Ltd. that is developing the SP-1 protein for cancer drug delivery and other applications.
'"/>

Source:Hebrew University of Jerusalem


Related biology news :

1. New, automated tool successfully classifies and relates proteins in unprecedented way
2. New binding target for oncogenic viral protein
3. Controversial drug shown to act on brain protein to cut alcohol use
4. Timing is everything: First step in protein building revealed
5. UWs Rosetta software to unlock secrets of many human proteins
6. Researchers find how protein allows insects to detect and respond to pheromones
7. Signaling protein builds bigger, better bones in mice
8. Ancient olfaction protein is shared by many bugs, offering new pest control target
9. Automatic extraction of gene/protein biological functions from biomedical text
10. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
11. Scientists develop new color-coded test for protein folding

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2018)... FRANCISCO (PRWEB) , ... October ... ... leading executive search firm for life sciences, diagnostics, and scientific healthcare companies, ... place October 25, 2018 in South San Francisco. In conjunction with co-producer ...
(Date:10/16/2018)... HOUSTON (PRWEB) , ... October 15, 2018 , ... ... integrated cold chain operations solutions for highly regulated industries, is a silver sponsor ... in San Diego, California. , The Biomanufacturing World Summit brings together ...
(Date:10/13/2018)... ... , ... HOLLOWAY AMERICA, a stainless steel pressure vessel fabrication ... EXPO International in Chicago from October 14 to 17. The annual event is ... a member. , At this year’s PACK EXPO at the McCormick Place exposition ...
Breaking Biology News(10 mins):
(Date:9/28/2018)... ... 28, 2018 , ... GlycoMark®, Inc. has announced a partnership ... test, the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic ... the GlycoMark test to its network of physicians through its sales organization and ...
(Date:9/27/2018)... ... September 26, 2018 , ... Consumers adopting new health care ... physicians, according to a new Zeldis Research and Schlesinger Group study, “The Consumerization ... consumer adoption of fitness and health wearables, remote monitoring, patient portals and other ...
(Date:9/27/2018)... (PRWEB) , ... September 27, 2018 , ... ... York City, Everwell Health Solutions and SureAdhere Mobile Technology, Inc. announced they will ... medication monitoring in the battle against tuberculosis (TB) and other diseases. These two ...
(Date:9/22/2018)... WESTMINSTER, Colo. (PRWEB) , ... ... ... Flagship Biosciences are excited to announce a strategic venture. The synergistic combination ... pathology platform provides complimentary and comprehensive biomarker profiling to empower clinical trials ...
Breaking Biology Technology: